Is IL-10 a good target to inhibit choroidal neovascularisation in age-related macular disease?

PLoS Medicine

Volumn 3, Issue 8, 2006, Pages 1218-1219

  Lightman, Sue ^a,b   Calder, Virginia ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b MOORFIELDS EYE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; INTERLEUKIN 10; INTERLEUKIN 10 ANTIBODY; PEGAPTANIB; RANIBIZUMAB; VASCULOTROPIN ANTIBODY; MONOCLONAL ANTIBODY;

BLINDNESS; CLINICAL TRIAL; DRUG INHIBITION; EYE INFLAMMATION; HUMAN; LOW LEVEL LASER THERAPY; MEDICAL RESEARCH; NONHUMAN; PHOTODYNAMIC THERAPY; RETINA MACULA AGE RELATED DEGENERATION; SHORT SURVEY; SUBRETINAL NEOVASCULARIZATION; UPREGULATION; ANIMAL; DISEASE MODEL; DRUG EFFECT; GENETICS; IMMUNOLOGY; MACROPHAGE; MOUSE; MOUSE MUTANT; NOTE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RETINA MACULA DEGENERATION; TREATMENT OUTCOME;

ANIMALS; ANTIBODIES, MONOCLONAL; CHOROIDAL NEOVASCULARIZATION; DISEASE MODELS, ANIMAL; HUMANS; INTERLEUKIN-10; MACROPHAGES; MACULAR DEGENERATION; MICE; MICE, KNOCKOUT; TREATMENT OUTCOME;

EID: 33748360767     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.0030364     Document Type: Short Survey

References (10)

1. Age-Related Eye Disease Study Research Group (2001) A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol 119: 1417-1436.
2. Michels S, Schmidt-Erfurth U, Rosenfeld PJ (2006) Promising new treatments for neovascular age-related macular degeneration. Expert Opin Investig Drugs 15: 779-793.
3. Apte RS, Richter J, Herndon J, Ferguson TA (2006) Macrophages inhibit neovascularization in a murine model of age-related macular degeneration. PLoS Med 3: e310. DOI:10.1371/journal.pmed.0030310
4. Muhaya M, Calder VL, Towler HM, Jolly G, McLauchlan M, et al. (1999) Characterization of phenotype and cytokine profiles of T cell lines derived from vitreous humour in ocular inflammation in man. Clin Exp Immunol 116: 410-414.
5. Koldzic-Zivanovic N, Tu H, Juelich TL, Rady PL, Tyring SK, et al. (2005) Regulation of adrenal glucocorticoid synthesis by interleukin-10: A preponderance of IL-10 receptor in the adrenal zona fasciculata. Brain Behav Immun. E-pub ahead of print.
6. McGeachy MJ, Anderton SM (2005) Cytokines in the induction and resolution of experimental autoimmune encephalomyelitis. Cytokine 32: 81-84.
7. Andoh A, Zhang Z, Inatomi O, Fujino S, Deguchi Y, et al. (2005) Interleukin-22, a member of the IL-10 subfamily, induces inflammatory responses in colonic subepithelial myofibroblasts. Gastroenterology 129: 969-984.
8. Wangoo A, Laban C, Cook HT, Glenville B, Shaw RJ (1997) Interleukin-10- and corticosteroid-induced reduction in type I procollagen in a human ex vivo scar culture. Int J Exp Pathol 78: 33-41.
9. Crawley E, Kay R, Sillibourne J, Patel P, Hutchinson I, et al. (1999) Polymorphic haplotypes of the interleukin-10 5′ flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis. Arthritis Rheum 42: 1101-1108.
10. O'Byrne PM, Inman MD, Parameswaran K (2001) The trials and tribulations of IL-5, eosinophils, and allergic asthma. J Allergy Clin Immunol 108: 503-508.